Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
文献类型：期刊论文
| 作者 | Lan, Xiaoying; Song, Wenbin; Lu, Xiaoyu; Liu, Shouting; Liu, Jinbao; Wang, Xuejun; Liu, Ningning; Li, Xiaofen; Huang, Hongbiao; Zhao, Chong |
| 刊名 | ONCOTARGET
 |
| 出版日期 | 2014 |
| 卷号 | 5期号:14页码:5453-5471 |
| ISSN号 | 1949-2553 |
| 学科主题 | Oncology ; Cell Biology |
| 语种 | 英语 |
| 源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/658]  |
| 专题 | 中国科学院广州生物医药与健康研究院 |
| 推荐引用方式 GB/T 7714 | Lan, Xiaoying,Song, Wenbin,Lu, Xiaoyu,et al. Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth[J]. ONCOTARGET,2014,5(14):5453-5471. |
| APA | Lan, Xiaoying.,Song, Wenbin.,Lu, Xiaoyu.,Liu, Shouting.,Liu, Jinbao.,...&Chen, Xin.(2014).Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth.ONCOTARGET,5(14),5453-5471. |
| MLA | Lan, Xiaoying,et al."Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth".ONCOTARGET 5.14(2014):5453-5471. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。